Patients with insufficient oxygen supply to the heart, or myocardial ischemia, may benefit from coronary intervention (PCI), such as stenting of partially occluded vessels. The course of treatment for patients with CAD depends on disease severity. While coronary angiography is always performed prior to PCI, it may underestimate or overestimate the severity of specific cardiac lesions. In contrast, Fractional Flow Reserve (FFR) provides a quantitative ratio of the actual blood flow in a narrowed artery, compared with the normal achievable blood flow and is more accurate in diagnosing ischemic lesions than angiography alone. Using this functional or morphological measurement, Fractional Flow Reserve (FFR) can quantify the severity of specific stenoses.
A 2012 report prepared by multiple cardiology medical societies addressed the use of FFR in appropriate use criteria for diagnostic cardiac catheterization. These appropriate use criteria recommend FFR for diagnostic evaluation of most CAD cases determined by angiography to be of intermediate, obstructive/significant or indeterminate severity. Further targeted
appropriate use criteria update for coronary revascularization were launched in the same year by various societies including the ACCF, SCAI, STS, AATS, AHA, ASNC, HFSA and SCCT. Within the criteria, the use of diagnostic cardiac catheterization
is recommended as an additional invasive measurement to determine the need for PCI for patients with coronary narrowing of uncertain severity.
The critical role of physiological fractional flow reserve (FFR), in guiding interventions is discussed at a number of cardiology conferences. One such cardiology conference is the European Society of Cardiology (ESC) 2014 which takes place in Barcelona this year. The ESC
hosts the world’s largest and most influential cardiovascular event every year in August. Record numbers of hot line sessions and abstracts were submitted this year and the congress is on track to host the largest number of delegates in its history.
